NorthCrest Asset Manangement’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Buy
40,697
+1,671
+4% +$147K 0.09% 170
2026
Q1
$3.55M Sell
39,026
-16,355
-30% -$1.5M 0.11% 161
2025
Q4
$5.13M Sell
55,381
-2,497
-4% -$237K 0.11% 144
2025
Q3
$5.73M Sell
57,878
-86
-0.1% -$8.52K 0.14% 133
2025
Q2
$5.43M Buy
57,964
+731
+1% +$70.7K 0.15% 131
2025
Q1
$6.48M Buy
57,233
+31
+0.1% +$3.32K 0.2% 118
2024
Q4
$6.04M Sell
57,202
-1,496
-3% -$161K 0.18% 126
2024
Q3
$6.34M Buy
58,698
+535
+0.9% +$58.4K 0.19% 123
2024
Q2
$6.31M Buy
58,163
+629
+1% +$74.1K 0.21% 124
2024
Q1
$7.59M Buy
57,534
+186
+0.3% +$23.2K 0.26% 110
2023
Q4
$6.98M Sell
57,348
-378
-0.7% -$42.2K 0.26% 107
2023
Q3
$6.48M Sell
57,726
-332
-0.6% -$42.2K 0.26% 112
2023
Q2
$8.45M Sell
58,058
-624
-1% -$84.8K 0.33% 97
2023
Q1
$7.58M Sell
58,682
-216
-0.4% -$27.1K 0.32% 104
2022
Q4
$7.51M Sell
58,898
-2,190
-4% -$254K 0.43% 84
2022
Q3
$6.39M Buy
61,088
+1,320
+2% +$145K 0.35% 105
2022
Q2
$6.28M Sell
59,768
-730
-1% -$86.6K 0.32% 107
2022
Q1
$7.74M Buy
60,498
+4,908
+9% +$592K 0.37% 97
2021
Q4
$6.86M Buy
+55,590
New +$7.28M 0.38% 86

Other funds holding ZBH

NorthCrest Asset Manangement's ZBH Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Zimmer Biomet (ZBH) stake by 4.3% in Q2 2026, buying an estimated $147K and bringing the position to 40,697 shares worth $3.63M. The position accounts for 0.09% of the portfolio, ranked #170.

NorthCrest Asset Manangement first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.45M in Q2 2023. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • NorthCrest Asset Manangement held 40,697 shares of Zimmer Biomet worth $3.63M as of Q2 2026.
  • NorthCrest Asset Manangement bought 1,671 Zimmer Biomet shares in Q2 2026, an estimated $147K.
  • Zimmer Biomet made up 0.09% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #170 holding.
  • NorthCrest Asset Manangement first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Zimmer Biomet position peaked at $8.45M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.